Benzoylmetronildazole

Common name: Metronidazole Benzoate
Molecular Formula: C₁₃H₁₃N₃O₄
Chemical Name: 1 - (2 - ethyl benzoate) -2 - methyl -5 - nitroimidazole
operative standard: BP, USP, EP
CAS No.: 13182-89-3
Property: White or light yellow crystalline powder, almost odorless and tasteless. in dichloromethane, chloroform, acetone soluble, slightly soluble in ethanol, almost insoluble in water. melting point of 99-102 ℃.
Category: Anti-amoebic drug, anti-trichomonad drugs, anti-anaerobic drugs.
Package: 25KG/paper barrel or packed according to the requirements of customers.
Shelf life: 4year (dry, dark and cold place)
Features: The product is new generation oral high effect, against anaerobes, antiprotozoal drugs. It is national Ⅳ series new drug. It is the domestic only one manufacturer. In 1993, WHO approved Benzoyl Metronidazole as Antimicrobial agents, anti-amebic and anti-insect, essential drugs pear-shaped. Benzoyl Metronidazole Capsule has function after in vivo hydrolysis of Metronidazole, In particular, dissolved in the body faster, which will help the body's absorption of the drug, the product has wide indications, a long half-life, high concentrations of drug action, side effects are minor and is a transient, non-resistance characteristics.
Use:
Application: Metronidazole Benzoate Capsule, BenzoylMetronidazole tablet, BenzoylMetronidazole suspension, benzene Metronidazole suspension.
Applications: 1. urogenital trichomoniasis, such as vaginal trichomoniasis, etc.; 2. intestinal and parenteral amebiasis, such as amebiasis and amebic liver abscess; 3. Jia trichomoniasis; 4. sensitive to a variety of infections caused by anaerobic bacteria, such as bacteria leukemia, sepsis infection after abdominal surgery; 5. Prevention of gynecological caused by the anaerobic bacteria, infection after surgery.